全文获取类型
收费全文 | 246020篇 |
免费 | 22063篇 |
国内免费 | 8932篇 |
专业分类
耳鼻咽喉 | 1960篇 |
儿科学 | 3912篇 |
妇产科学 | 2865篇 |
基础医学 | 38312篇 |
口腔科学 | 4020篇 |
临床医学 | 18635篇 |
内科学 | 42193篇 |
皮肤病学 | 3845篇 |
神经病学 | 18536篇 |
特种医学 | 4971篇 |
外国民族医学 | 61篇 |
外科学 | 17162篇 |
综合类 | 32326篇 |
现状与发展 | 27篇 |
一般理论 | 6篇 |
预防医学 | 13886篇 |
眼科学 | 2966篇 |
药学 | 39803篇 |
48篇 | |
中国医学 | 10879篇 |
肿瘤学 | 20602篇 |
出版年
2023年 | 4245篇 |
2022年 | 5510篇 |
2021年 | 10617篇 |
2020年 | 9153篇 |
2019年 | 8687篇 |
2018年 | 8504篇 |
2017年 | 8201篇 |
2016年 | 8237篇 |
2015年 | 9477篇 |
2014年 | 14665篇 |
2013年 | 16539篇 |
2012年 | 14516篇 |
2011年 | 16837篇 |
2010年 | 13990篇 |
2009年 | 13606篇 |
2008年 | 13149篇 |
2007年 | 12039篇 |
2006年 | 10763篇 |
2005年 | 9421篇 |
2004年 | 7958篇 |
2003年 | 7165篇 |
2002年 | 5751篇 |
2001年 | 4766篇 |
2000年 | 3937篇 |
1999年 | 3475篇 |
1998年 | 2861篇 |
1997年 | 2744篇 |
1996年 | 2390篇 |
1995年 | 2423篇 |
1994年 | 2201篇 |
1993年 | 1913篇 |
1992年 | 1620篇 |
1991年 | 1534篇 |
1990年 | 1284篇 |
1989年 | 1072篇 |
1988年 | 1034篇 |
1987年 | 837篇 |
1986年 | 778篇 |
1985年 | 1689篇 |
1984年 | 1883篇 |
1983年 | 1425篇 |
1982年 | 1542篇 |
1981年 | 1381篇 |
1980年 | 1077篇 |
1979年 | 954篇 |
1978年 | 659篇 |
1977年 | 540篇 |
1976年 | 580篇 |
1975年 | 425篇 |
1973年 | 274篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
41.
《Vaccine》2022,40(32):4440-4452
Coronavirus disease 2019 (COVID-19) is an acute respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The prevention of SARS-CoV-2 transmission has become a global priority. Previously, we showed that a protein subunit vaccine that was developed based on the fusion of the SARS-CoV-2 receptor-binding domain (RBD) to the Fc portion of human IgG1 (RBD-Fc), produced in Nicotiana benthamiana, and adjuvanted with alum, namely, Baiya SARS-CoV-2 Vax 1, induced potent immunological responses in both mice and cynomolgus monkeys. Hence, this study evaluated the protective efficacy, safety, and toxicity of Baiya SARS-CoV-2 Vax 1 in K18-hACE2 mice, monkeys and Wistar rats. Two doses of vaccine were administered three weeks apart on Days 0 and 21. The administration of the vaccine to K18-hACE2 mice reduced viral loads in the lungs and brains of the vaccinated animals and protected the mice against challenge with SARS-CoV-2. In monkeys, the results of safety pharmacology tests, general clinical observations, and a core battery of studies of three vital systems, namely, the central nervous, cardiovascular, and respiratory systems, did not reveal any safety concerns. The toxicology study of the vaccine in rats showed no vaccine-related pathological changes, and all the animals remained healthy under the conditions of this study. Furthermore, the vaccine did not cause any abnormal toxicity in rats and was clinically tolerated even at the highest tested concentration. In addition, general health status, body temperature, local toxicity at the administration site, hematology, and blood chemistry parameters were also monitored. Overall, this work presents the results of the first systematic study of the safety profile of a plant-derived vaccine, Baiya SARS-CoV-2 Vax 1; this approach can be considered a viable strategy for the development of vaccines against COVID-19. 相似文献
42.
目的 对比研究朝鲜淫羊藿酸性多糖酯化还原前后的理化特性,并探讨其改善油酸诱导的肝癌HepG2细胞脂质堆积活性的差异。方法 采用高效凝胶渗透色谱法测定朝鲜淫羊藿酸性多糖(EFPA)的均一性和分子量,高效液相色谱法测定EFPA和酯化还原后朝鲜淫羊藿酸性多糖(EFPA-R)的单糖组成;采用油酸(OA)处理HepG2细胞诱导建立脂质蓄积模型,不同浓度EFPA与EFPA-R(10、30、100、300 μg·mL-1)分别和OA共同作用于细胞24 h,采用CCK-8试剂盒测定细胞存活率,油红O染色观察细胞内脂滴蓄积情况,并采用试剂盒测定细胞内总胆固醇(TC)、甘油三酯(TG)含量。结果 EFPA为成分均一的多糖组分,分子量为125.8 kDa,由甘露糖、葡萄糖、半乳糖、葡萄糖醛酸和阿拉伯糖组成,摩尔比为1.7∶7.4∶1.4∶1.8∶1.0,葡萄糖占比最大,EFPA-R由甘露糖、葡萄糖、半乳糖和阿拉伯糖组成,摩尔比为0.8∶10.6∶2.1∶1.0;在10-300 μg·mL-1范围内,EFPA和EFPA-R对HepG2细胞的抑制作用较弱,作为给药浓度;与空白组相比,模型组细胞中TC、TG含量显著升高(P < 0.01),细胞内红色脂滴显著增多,与模型组相比,EFPA可显著降低细胞中TC、TG含量(P < 0.01),明显减少细胞内红色脂滴(P < 0.05或P < 0.01),EFPA-R干预后细胞则无明显变化。结论 EFPA可明显改善HepG2细胞脂质堆积情况,且呈现剂量依赖性,而半乳糖醛酸(GalA)的存在可能是其抑制HepG2细胞脂质蓄积的关键因素。 相似文献
43.
《European journal of surgical oncology》2022,48(6):1264-1271
BackgroundIn order to avoid excessive treatment of thyroid nodules in the clinic, it is necessary to find a simple and practical analysis method to comprehensively and accurately reflect benign or malignant thyroid nodules. This study aimed to construct and validate a comprehensive and reliable network-based predictive model using a variety of imaging and laboratory criteria for thyroid nodules to stratify the risk of malignancy prior to surgery.MethodsWe retrospectively analyzed data from patients who underwent surgical treatment for thyroid nodules at the Thyroid and Breast Diagnosis and Treatment Center of Weifang Hospital of Traditional Chinese Medicine between January 2018 and December 2020. Binary logical regression analysis was performed to predict whether nodules were malignant or benign. The developmental dataset included 457 patients (January 2018–December 2020). The validation set included separate data points (n = 225, January 2018–December 2020).ResultsIn this study, criteria that showed significant predictive value for malignant nodules included TI-RADS: 4b (p = 0.065); Bethesda IV, Bethesda V, Bethesda VI (P < 0.0001); BRAFV600E mutation (P < 0.0001); Calcitonin>5 pg/ml (p = 0.0037); and FNA-Tg>30 ng/ml (p = 0.0003). A 10-grade risk scoring system was developed. The risk of malignancy risk ranged from 2.06% to 100% and was positively associated with increasing risk grade. The areas under the receiver-operating characteristic curve of the development and validation sets were 0.972 and 0.946, respectively.ConclusionA simple, comprehensive and reliable web-based predictive model was designed using a variety of imaging and laboratory criteria to stratify thyroid nodules by probability of malignancy. 相似文献
44.
《Drug discovery today》2022,27(9):2551-2561
B cell lymphoma 2 (BCL2) overexpression in a range of human tumors is often related to chemotherapy resistance and poor prognosis. GC-rich regions upstream of the P1 promoter in human BCL2 can form G-quadruplex (G4) structures through the stacking of four Hoogsteen-paired guanine bases. Stabilizing the G4 fold implies the inhibition of BCL2 expression and, thus, small molecules that selectively bind to the G4 are promising anticancer candidates. In this review, we discuss the structural aspects, binding affinity, selectivity, and biological activity of well-characterized BCL2 G4 binding ligands in vitro and in vivo. We also explore future directions in the research and development of G4-based anticancer therapeutics. 相似文献
45.
46.
姚峰 《中国工业医学杂志》2022,35(2):191-191